Dr. Ann Tsukamoto is currently the Executive Vice President of Research & Development for StemCells, Inc., a biopharmaceutical company that specializes in the study, advancement, and commercialization of stem cell therapies and related technology. She received her Ph.D. from the University of California, Los Angeles. In 1991, Tsukamoto became a co-patentee of the process to isolate human stem cells, and is also an inventor on six stem cell-related U.S. patents. With her direction and 20+ years of experience, the StemCells, Inc. team has isolated the human neural stem cell, a mass of human liver transplanting cells and an entrant pancreas stem cell. Her work has majorly advanced the knowledge of the blood systems of cancer patients, getting us steps closer to finding a cure for the disease.
This entry is part of MPL's National Women's History Month.